[go: up one dir, main page]

MX2016011842A - Composiciones tópicas de corticosteroides. - Google Patents

Composiciones tópicas de corticosteroides.

Info

Publication number
MX2016011842A
MX2016011842A MX2016011842A MX2016011842A MX2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A MX 2016011842 A MX2016011842 A MX 2016011842A
Authority
MX
Mexico
Prior art keywords
compositions
topical corticosteroid
skin
corticosteroid compositions
disorders
Prior art date
Application number
MX2016011842A
Other languages
English (en)
Other versions
MX381164B (es
Inventor
Kandavalli Sateesh
Sahukar Priyadarshani
Okumu Franklin
Original Assignee
Promius Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promius Pharma Llc filed Critical Promius Pharma Llc
Publication of MX2016011842A publication Critical patent/MX2016011842A/es
Publication of MX381164B publication Critical patent/MX381164B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones para la administración tópica de un agente activo que comprenden un corticosteroide y un alcohol graso como aumentador de penetración en la piel, en la forma de rocíos tópicos. Procesos para preparar tales composiciones y métodos para usarlas en el manejo de enfermedades o trastornos de la piel tales como psoriasis, dermatosis, y otras enfermedades o trastornos de la piel asociados.
MX2016011842A 2014-03-11 2015-03-11 Composiciones tópicas de corticosteroides. MX381164B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461951165P 2014-03-11 2014-03-11
PCT/US2015/020031 WO2015138650A1 (en) 2014-03-11 2015-03-11 Topical corticosteroid compositions

Publications (2)

Publication Number Publication Date
MX2016011842A true MX2016011842A (es) 2017-02-02
MX381164B MX381164B (es) 2025-03-12

Family

ID=52727460

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016011842A MX381164B (es) 2014-03-11 2015-03-11 Composiciones tópicas de corticosteroides.
MX2016011841A MX2016011841A (es) 2014-03-11 2015-09-09 Composiciones topicas de corticosteroides.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2016011841A MX2016011841A (es) 2014-03-11 2015-09-09 Composiciones topicas de corticosteroides.

Country Status (13)

Country Link
US (4) US20150258119A1 (es)
EP (2) EP3116473B1 (es)
JP (2) JP6487949B2 (es)
KR (2) KR101930244B1 (es)
CN (1) CN106659682B (es)
AU (2) AU2015229403B2 (es)
BR (1) BR112016021023A2 (es)
CA (2) CA2945943C (es)
EA (2) EA201691808A8 (es)
ES (1) ES2857602T3 (es)
MX (2) MX381164B (es)
WO (2) WO2015138650A1 (es)
ZA (1) ZA201606704B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2473161T3 (en) 2009-08-31 2017-09-11 Dr Reddys Laboratories Ltd TOPICAL FORMULATIONS INCLUDING A STEROID
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2017091168A1 (en) * 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. A topical spray comprising isoconazole nitrate and difluocortolone valerate
JP6905994B2 (ja) * 2016-01-12 2021-07-21 ノーティック ホールディングス インコーポレイテッド ベタメタゾン経口スプレー製剤及び運動失調の治療への使用方法
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
US20180028766A1 (en) * 2016-07-27 2018-02-01 Sun Pharmaceutical Industries Limited Touch-free topical spray of halobetasol
CA3037582A1 (en) 2016-09-21 2018-03-29 Avexxin As Pharmaceutical composition
US10543177B2 (en) 2017-04-11 2020-01-28 Kevin Mrohs Composition and method for treating skin conditions
US11620886B2 (en) 2018-02-19 2023-04-04 Invue Security Products Inc. Merchandise security system with inductive charging
JP2022508512A (ja) * 2018-09-28 2022-01-19 ジョエル スタディン ステロイド及び巨大分子の経穴送達
JP7412292B2 (ja) * 2019-07-10 2024-01-12 積水化学工業株式会社 製剤
WO2021080527A1 (en) * 2019-10-24 2021-04-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. Topical pharmaceutical compositions containing difluocortolone and isoconazole
WO2021162796A1 (en) * 2020-02-11 2021-08-19 Taro Pharmaceutical Industries Ltd. Compositions comprising desoximetasone and tazarotene
US11382863B2 (en) * 2020-03-04 2022-07-12 Somerset Therapeutics Llc Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid
CN113092601B (zh) * 2021-03-02 2022-12-20 苏州市药品检验检测研究中心 一种化妆品中倍他米松17-丙酸酯及倍他米松21-丙酸酯的检测方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892856A (en) 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
WO1991008733A1 (en) * 1989-12-20 1991-06-27 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
IT1247529B (it) 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
ATE223202T1 (de) 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
AU2004313285A1 (en) * 2003-12-16 2005-09-29 Foamix Ltd Oleaginous pharmaceutical and cosmetic foam
AR051197A1 (es) * 2004-08-31 2006-12-27 Connetics Australia Pty Ltd Un procedimiento para obtener una microemulsion y sub-micron emulsion y composiciones
CA2756674C (en) * 2004-08-31 2012-04-03 Stiefel Research Australia Pty Ltd Microemulsion & sub-micron emulsion process & compositions
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
ES2539634T3 (es) 2005-04-25 2015-07-02 Dow Pharmaceutical Sciences Uso de una formulación de clobetasol en forma de pulverización para tratar la psoriasis
GB2443162B (en) 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
DK2473161T3 (en) * 2009-08-31 2017-09-11 Dr Reddys Laboratories Ltd TOPICAL FORMULATIONS INCLUDING A STEROID
US10029013B2 (en) * 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
NL2004437C2 (en) * 2010-03-19 2011-09-20 Forte Iq B V Spray-pumpable comprising composition suitable for topical skin application.
JP5865360B2 (ja) * 2010-06-11 2016-02-17 プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． 油分高濃度配合軟化性エアロゾル発泡組成物
CN104540801B (zh) * 2012-08-10 2016-05-18 旭硝子株式会社 碳酸酯化合物及芳香族聚碳酸酯的制造方法
EP2968572A1 (en) * 2013-03-15 2016-01-20 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
US10111956B2 (en) * 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions

Also Published As

Publication number Publication date
WO2016144381A1 (en) 2016-09-15
CA2945943A1 (en) 2015-09-17
KR20170023791A (ko) 2017-03-06
AU2015385750A1 (en) 2016-10-27
CN106659682A (zh) 2017-05-10
AU2015385750B2 (en) 2019-01-31
EP3116473B1 (en) 2020-12-30
EA201691808A1 (ru) 2017-02-28
US20160030450A1 (en) 2016-02-04
EP3197432A1 (en) 2017-08-02
KR101930246B1 (ko) 2018-12-18
EP3197432A4 (en) 2018-10-10
AU2015229403B2 (en) 2019-05-02
EA201691808A8 (ru) 2017-04-28
JP6535735B2 (ja) 2019-06-26
ES2857602T3 (es) 2021-09-29
JP2017508802A (ja) 2017-03-30
AU2015229403A1 (en) 2016-10-27
BR112016021023A8 (pt) 2018-01-30
CA2946201A1 (en) 2016-09-15
US20200230155A1 (en) 2020-07-23
CA2946201C (en) 2020-10-27
WO2015138650A1 (en) 2015-09-17
MX2016011841A (es) 2017-02-02
EP3116473A1 (en) 2017-01-18
US20150258119A1 (en) 2015-09-17
ZA201606704B (en) 2019-07-31
BR112016021023A2 (pt) 2021-09-14
CN106659682B (zh) 2020-12-29
KR101930244B1 (ko) 2018-12-18
EA201692334A1 (ru) 2018-02-28
MX381164B (es) 2025-03-12
CA2945943C (en) 2020-10-27
JP2017530974A (ja) 2017-10-19
JP6487949B2 (ja) 2019-03-20
US20180250312A1 (en) 2018-09-06
KR20160144377A (ko) 2016-12-16

Similar Documents

Publication Publication Date Title
MX2016011842A (es) Composiciones tópicas de corticosteroides.
CO2018001375A2 (es) Composiciones de retinoides tópicos
ZA201806163B (en) Microneedle patch for delivering an active ingredient to skin
NI201600071A (es) Compuestos de inhibidor de autotaxina
CO2017001493A2 (es) Kits que comprenden inhibidores tigit y agentes anticáncer
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
BR112016023815A2 (pt) composições tópicas para o alívio da dor, produção e uso
MX2019010757A (es) Métodos y composiciones relacionados con el tratamiento combinado con antiinflamatorios y nanoportadores sintéticos que comprenden un inmunosupresor.
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
MX2017006113A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
MX385762B (es) Métodos para el control transcripcional objetivo en regiones del super mejorador.
CO2017002472A2 (es) Formulación de acetato de abiraterona
HUE044885T2 (hu) Hatóanyagok társítása topikális alkalmazásra bõrbetegségek utáni megváltozott bõr barrier újra strukturálására
ECSP15033898A (es) Composición antifúngica tópica para el tratamiento de onicomicosis
GT201400146A (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
MX2015013151A (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
MX384637B (es) Compuestos oxadiazoespíricos para el tratamiento del abuso y la adicción a las drogas.
BR112018012349A2 (pt) composição farmacêutica espumante, composição espumante de armazenamento estável e método para tratar um indivíduo com, ou em risco de ter, uma doença, condição ou distúrbio da pele
CR20160116A (es) Método para tratar onicomicosis con hidroxipropil quitasano
PT3273942T (pt) Penso de microagulhas para administração de um ingrediente ativo na pele
UA92452U (ru) Способ заживления местных лучевых повреждений кожи
UA92219U (ru) Лекарственное средство с метронидазолом для лечения дерматологических заболеваний